Skip to main content
Premium Trial:

Request an Annual Quote

Brian Meshkin, Michael Leavitt; Jean-Pierre Millon, Don Williams

Proove Biosciences appointed its Founder and CEO Brian Meshkin, along with three others, to its board. They are Michael Levitt, Jean-Pierre Millon, and Don Williams. 

Leavitt is the former governor of Utah and secretary of the US Department of Health and Human Services. Millon is the former president and CEO of PCS Health Systems and a board member of CVS Health, and Williams is the former national leader of audit, tax, and advisory firm Grant Thornton's life sciences practice.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.